IFNB1 and infection: The addition of exogenous IFNβ successfully inhibited ZIKV replication in the testis explants, as evidenced by the significant reduction of ZIKV RNA release from 3-day post-infection onwards when compared with untreated explants, and by the lack of viral load increase over time in IFNβ-treated explants (Figure 7C).